Published in J Invest Dermatol on July 01, 1984
Epitope mapping of type VII collagen. Identification of discrete peptide sequences recognized by sera from patients with acquired epidermolysis bullosa. J Clin Invest (1993) 1.16
Autoantibodies to type VII collagen mediate Fcgamma-dependent neutrophil activation and induce dermal-epidermal separation in cryosections of human skin. Am J Pathol (2002) 1.01
The role of complement-derived mediators in inflammatory skin diseases. Arch Dermatol Res (1992) 0.86
Bullous pemphigoid antigen concentration in normal human skin in relation to body area and age. Arch Dermatol Res (1988) 0.84
Autoantibodies to type VII collagen have heterogeneous subclass and light chain compositions and their complement-activating capacities do not correlate with the inflammatory clinical phenotype. J Clin Immunol (2000) 0.77
Utility of immunofluorescence in dermatology. Indian Dermatol Online J (2017) 0.75
Clearing of epidermolysis bullosa acquisita with cyclosporine. J Am Acad Dermatol (1988) 2.00
Limitations and relative utility of screening assays to assess engineered nanoparticle toxicity in a human cell line. Toxicol Appl Pharmacol (2008) 1.99
Differentiating anti-lamina lucida and anti-sublamina densa anti-BMZ antibodies by indirect immunofluorescence on 1.0 M sodium chloride-separated skin. J Invest Dermatol (1984) 1.85
Epidermolysis bullosa dystrophica-recessive: a possible role of anchoring fibrils in the pathogenesis. J Invest Dermatol (1975) 1.80
Identification of the skin basement-membrane autoantigen in epidermolysis bullosa acquisita. N Engl J Med (1984) 1.80
The epidermal-dermal junction. J Invest Dermatol (1975) 1.60
Formation and origin of basal lamina and anchoring fibrils in adult human skin. J Cell Biol (1971) 1.48
Eczema herpeticum, primary and recurrent. Arch Dermatol (1966) 1.41
Cutaneous plasmacytomas. A review and presentation of an unusual case. J Am Acad Dermatol (1979) 1.38
Pathogenesis of recurrent herpes simplex infections. J Invest Dermatol (1975) 1.28
An in vitro model of immune complex-mediated basement membrane zone separation caused by pemphigoid antibodies, leukocytes, and complement. J Invest Dermatol (1982) 1.23
Comparative efficacy of oral erythromycin versus oral tetracycline in the treatment of acne vulgaris. A double-blind study. J Am Acad Dermatol (1986) 1.17
A case of linear IgA disease presenting initially with IgG immune deposits. J Am Acad Dermatol (1986) 1.14
Epidermal-dermal interactions in adult human skin: role of dermis in epidermal maintenance. J Invest Dermatol (1968) 1.12
Epiligrin, the major human keratinocyte integrin ligand, is a target in both an acquired autoimmune and an inherited subepidermal blistering skin disease. J Clin Invest (1992) 1.09
In vivo suppression of neutrophil chemotaxis by systemically and topically administered tetracycline. J Am Acad Dermatol (1983) 1.09
Safety evaluation of sunscreen formulations containing titanium dioxide and zinc oxide nanoparticles in UVB sunburned skin: an in vitro and in vivo study. Toxicol Sci (2011) 1.09
Pemphigoid antibody mediated attachment of peripheral blood leukocytes at the dermal-epidermal junction of human skin. J Invest Dermatol (1980) 1.08
Epidermolysis bullosa acquisita antigen, a major cutaneous basement membrane component, is synthesized by human dermal fibroblasts and other cutaneous tissues. J Invest Dermatol (1986) 1.05
Mechanism of lesion production in pemphigus and pemphigoid. J Am Acad Dermatol (1982) 1.04
Cutaneous manifestations of disseminated cryptococcosis. Arch Dermatol (1976) 1.01
Epidermolysis bullosa acquisita--a pemphigoid-like disease. J Am Acad Dermatol (1984) 0.99
Preparation and characterization of a viable suspension of postembryonic human epidermal cells. J Invest Dermatol (1967) 0.99
Lamellar ichthyosis: long-term graft studies on congenitally athymic nude mice. J Invest Dermatol (1976) 0.98
A mouse monoclonal antibody against a newly discovered basement membrane component, the epidermolysis bullosa acquisita antigen. J Invest Dermatol (1985) 0.98
Discrimination between two strains (types) of Herpes simplex virus by various modifications of the neutralization test. J Immunol (1969) 0.95
Comparison of an in vitro skin model to normal human skin for dermatological research. Microsc Res Tech (1997) 0.94
Epidermolysis bullosa acquisita antigen is synthesized by human keratinocytes cultured in serum-free medium. Biochem Biophys Res Commun (1985) 0.93
In vitro toxicity assessment of three hydroxylated fullerenes in human skin cells. Toxicol In Vitro (2011) 0.93
The neonatal lupus syndrome associated with U1RNP (nRNP) antibodies. N Engl J Med (1987) 0.92
Immunodominant autoepitopes of type VII collagen are short, paired peptide sequences within the fibronectin type III homology region of the noncollagenous (NC1) domain. J Invest Dermatol (1995) 0.92
Immunohistochemical characterization of the basement membrane epitopes in bis(2-chloroethyl) sulfide-induced toxicity in mouse ear skin. J Appl Toxicol (1999) 0.92
Lamellar ichthyosis, dwarfism, mental retardation, and hair shaft abnormalities. A link between the ichthyosis-associated and BIDS syndromes. J Am Acad Dermatol (1980) 0.88
Direct immunofluorescence microscopy of 1 mol/L sodium chloride-treated patient skin. J Am Acad Dermatol (1991) 0.88
Epidermolysis bullosa acquisita antigen, a new major component of cutaneous basement membrane, is a glycoprotein with collagenous domains. J Invest Dermatol (1986) 0.88
Bullous systemic lupus erythematosus. J Am Acad Dermatol (1982) 0.87
The American Journal of Nursing and the socialization of a profession, 1900-1920. ANS Adv Nurs Sci (1985) 0.87
Evidence that anti-basement membrane zone antibodies in bullous eruption of systemic lupus erythematosus recognize epidermolysis bullosa acquisita autoantigen. J Invest Dermatol (1985) 0.86
Phosphocreatine protects ATP from a fructose load in transgenic mouse liver expressing creatine kinase. Am J Physiol (1991) 0.86
Passive transfer of autoantibodies from a patient with mutilating epidermolysis bullosa acquisita induces specific alterations in the skin of neonatal mice. Arch Dermatol (1995) 0.86
Identification of the pathway of iontophoretic drug delivery: light and ultrastructural studies using mercuric chloride in pigs. Pharm Res (1994) 0.86
Hyperpigmentation in megaloblastic anemia. J Am Acad Dermatol (1985) 0.86
Cutaneous IgA deposits in bullous diseases function as ligands to mediate adherence of activated neutrophils. J Invest Dermatol (1990) 0.85
Effect of selective lipid extraction from different body regions on epidermal barrier function. Pharm Res (2001) 0.85
Familial cutaneous collagenoma. Report of cases. Arch Dermatol (1968) 0.85
Efficacy of topical phenol decontamination strategies on severity of acute phenol chemical burns and dermal absorption: in vitro and in vivo studies in pig skin. Toxicol Ind Health (2001) 0.85
Specific affinity between fibronectin and the epidermolysis bullosa acquisita antigen. J Clin Invest (1987) 0.85
Immunology of human warts. J Am Acad Dermatol (1979) 0.85
Antiepiligrin cicatricial pemphigoid. A subepithelial bullous disorder. Arch Dermatol (1994) 0.85
Production of fibronectin by epithelium in a skin equivalent. J Invest Dermatol (1987) 0.84
The presence of intra-lamina lucida blister formation in epidermolysis bullosa acquisita: possible role of leukocytes. J Invest Dermatol (1989) 0.84
Epidermal-dermal interactions in adult human skin. II. The nature of the dermal influence. J Invest Dermatol (1971) 0.84
Epidermolysis bullosa acquisita of the immunopathological type (dermolytic pemphigoid). J Invest Dermatol (1985) 0.84
Childhood epidermolysis bullosa acquisita. Report of three cases and review of literature. J Am Acad Dermatol (1991) 0.83
Functional evidence for complement-activating immune complexes in the skin of patients with bullous pemphigoid. J Invest Dermatol (1982) 0.83
Organ-specific, phylogenetic, and ontogenetic distribution of the epidermolysis bullosa acquisita antigen. J Invest Dermatol (1986) 0.83
Systemic lupus erythematosus presenting as a bullous eruption in a child. Arch Dermatol (1988) 0.82
The carboxyl-terminal domain of type VII collagen is present at the basement membrane in recessive dystrophic epidermolysis bullosa. J Invest Dermatol (1989) 0.82
Leukemia cutis in acute myelomonocytic leukemia. Preferential localization in a recent Hickman catheter scar. Arch Dermatol (1987) 0.82
Leukocyte chemotaxis to the dermal-epidermal junction of human skin mediated by pemphigoid antibody and complement: mechanism of cell attachment in the in vitro leukocyte attachment method. J Invest Dermatol (1981) 0.82
Ultrastructural characterization of sulfur mustard-induced vesication in isolated perfused porcine skin. Microsc Res Tech (1997) 0.81
Demonstration of the complement regulating protein, beta 1H, in skin biopsies from patients with bullous pemphigoid. J Invest Dermatol (1979) 0.81
Electron microscopic observations of stratum corneum intercellular lipids in normal and atopic dogs. Vet Pathol (2001) 0.80
Peace and power. A handbook of feminist process. NLN Publ (1991) 0.80
Epidemic cutaneous herpes simplex in wrestlers (herpes gladiatorum). JAMA (1965) 0.80
A bullous skin disease patient with autoantibodies against separate epitopes in 1 mol/L sodium chloride split skin. Arch Dermatol (1992) 0.80
Epidermolysis bullosa acquisita presenting as an inflammatory bullous disease. J Am Acad Dermatol (1982) 0.80
Inhibition of neutrophil adherence to antibody by dapsone: a possible therapeutic mechanism of dapsone in the treatment of IgA dermatoses. J Invest Dermatol (1993) 0.80
Pemphigus foliaceus. Early clinical appearance as dermatitis herpetiformis with eosinophilic spongiosis. Arch Dermatol (1976) 0.80
Indirect immunohistochemistry and immunoelectron microscopy distribution of eight epidermal-dermal junction epitopes in the pig and in isolated perfused skin treated with bis (2-chloroethyl) sulfide. Toxicol Pathol (1995) 0.79
Topical penetration of piroxicam is dependent on the distribution of the local cutaneous vasculature. Pharm Res (1993) 0.79
Plaque titration of herpes simplex with antibody-free liquid overlay. Proc Soc Exp Biol Med (1968) 0.79
Determination of lidocaine concentrations in skin after transdermal iontophoresis: effects of vasoactive drugs. Pharm Res (1992) 0.78
Scleredema adultorum of Buschke and diabetes mellitus. Arch Dermatol (1970) 0.78
Secondary cutaneous mucinosis with systemic lupus erythematosus. A case presentation and review of the literature. Arch Dermatol (1978) 0.78
The fine structure of Culicinomyces clavisporus invading mosquito larvae. J Invertebr Pathol (1983) 0.78
A comparison of Cleocin T Solution, Cleocin T Gel, and placebo in the treatment of acne vulgaris. Cutis (1988) 0.77
Effect of JP-8 jet fuel exposure on protein expression in human keratinocyte cells in culture. Toxicol Lett (2005) 0.77
Heavy and light chain isotypes of immunoglobulin in epidermolysis bullosa acquisita. J Invest Dermatol (1990) 0.76
Relationship of beta 1H globulin and cleavage fragments of the third component of complement in the skin of patients with bullous pemphigoid and dermatitis herpetiformis. Clin Immunol Immunopathol (1981) 0.76
Acquired epidermolysis bullosa. A bullous disease associated with autoimmunity to type VII (anchoring fibril) collagen. Dermatol Clin (1990) 0.76
Epidermolysis bullosa acquisita in a patient with multiple endocrinopathies syndrome. Arch Dermatol (1986) 0.76
Intrauterine herpes simplex infections. Arch Dermatol (1977) 0.76
Bullous systemic lupus erythematosus: an unusual clinical course and detectable circulating autoantibodies to the epidermolysis bullosa acquisita antigen. J Am Acad Dermatol (1986) 0.76
Evidence supporting a role for immune complex-mediated inflammation in the pathogenesis of bullous lesions of systemic lupus erythematosus. J Invest Dermatol (1983) 0.75
OBSERVATIONS ON THE OPSONIC INDEX OF PATIENTS UNDERGOING SANATORIUM TREATMENT FOR PHTHISIS, WITH SPECIAL REFERENCE TO THE EFFECT OF EXERCISE. Br Med J (1905) 0.75
Graduate training in dermatology. Perspectives. Panel discussion. Arch Dermatol (1969) 0.75
Growth of herpes simplex virus in adult human skin organ cultures. Proc Soc Exp Biol Med (1969) 0.75
Our world of symbols. J Contin Educ Nurs (1972) 0.75
Skin manifestations of internal malignancy. Postgrad Med (1967) 0.75